We have Ranked, Sorted and Summarized the Latest Clinical Articles with Full Text Available.

1Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapyAnnals of Oncology, October 08, 2012  Full Text  Clinical Article
2Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphomaAnnals of Oncology, October 08, 2012  Full Text
3Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, 3, in Patients with Metastatic MelanomaClinical Cancer Research, October 08, 2012  Full Text  Clinical Article
4A Phase I Dose Esclation Study of Tivantinib in Adult Pts w Metastatic Solid TumorsClinical Cancer Research, October 08, 2012  Full Text  Clinical Article
5Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258)-an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors-in Patients with Advanced MelanomaClinical Cancer Research, October 08, 2012  Full Text  Clinical Article
6Repeated and Aggressive Pulmonary Resections for Leiomyosarcoma Metastases Extends SurvivalAnnals of Thoracic Surgery, October 08, 2012  Full Text
7HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDSBlood, October 08, 2012  Full Text
8Pam50 breast cancer subtyping by RT-QPCR and concordance with standard clinical molecular markersBMC Genomics, October 08, 2012  Full Text
9Breast vibro-acoustography: initial results show promiseBreast Cancer Research, October 08, 2012  Full Text
10Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomesBreast Cancer Research, October 08, 2012  Full Text

Show Me:

We have Ranked, Sorted and Summarized the Latest Clinical Articles with Full Text Available.

1Studies evaluate effectiveness of active surveillance in prostate cancer patientsAmerican Urological Association News, May 28, 2015
2Resolving a lymphatic riddleWeizmann Institute of Science News, May 28, 2015
3Massey researcher leads team to improve data reporting of meningioma treatment outcomes nationwideVirginia Commonwealth University News, May 28, 2015
4Only one in ten Australians warned of medical overdiagnosis risks by doctorsThe University of Sydney News, May 28, 2015
5Nanotechnology identifies brain tumor types through MRI "virtual biopsy" in animal studiesCedars-Sinai, May 28, 2015
6Researchers discover molecular approach to promote cancer cell deathEmory's Woodruff Health Sciences Center News, May 28, 2015
7Attitudes about complementary and alternative medicine predict use among cancer patients, Penn's Abramson Cancer Center findsPenn Medicine, May 28, 2015
8Pitt team IDs two new and very large classes of RNAs linked to an important cancer biomarkerUPMC, May 28, 2015
9False breast cancer alarm has negative impact on healthUniversity of Copenhagen Faculty of Health and Medical Sciences News, May 28, 2015
10Kaiser Permanente study finds blood-thinning bridge therapy may be harmful for patients at low to moderate risk for blood clotsKaiser Permanente Health Research News, May 28, 2015

Show Me:

CHD7 associated with survival in pancreatic ductal adenocarcinoma patients receiving gemcitabine

As reported in Cancer Research, low CHD7 expression is associated with increased RFS and OS in pancreatic ductal adenocarcinoma patients receiving gemcitabine. There was no association between CHD7 expression and RFS or OS in patients who were not treated with gemcitabine.

VPAC1 overexpression associated with colon cancer aggression

As reported in Tumor Biology, VPAC1 expression is increased in poorly differentiated compared to well-differentiated colon cancer. VPAC1 expression is also increased in the blood vessels and macrophages adjacent to colon cancer tissues compared to healthy tissues. The overexpression of VPAC1 is related to EGFR overexpression.

Cisplatin monotherapy effective in pediatric high-risk hepatoblastoma

As reported in the Journal of Pediatric Hematology/Oncology, treatment of children with high-risk hepatoblastoma (n=14) with cisplatin monotherapy was as effective as cisplatin + doxorubicin combination therapy, but with less toxicity. The complete resection rate was 78.6%, the event-free survival rate was 81.8%, and the OS rate was 100%.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocRenal carcinoma rates are rising among children and adolescents in the US.

Clinical Pearl from Smartest DocStrong claudin 5 expression in pancreatic adenocarcinoma is associated with worse survival.

Clinical Pearl from Smartest DocKRAS mutant allele-specific imbalance and gene amplification correlate with the progression of ductal adenocarcinomas to undifferentiated tumors.

New! Conference Interviews

Video Interview

Conference reports and videos; experts discuss new research! See the Latest Highlights